Research
Neural
GLP-1 receptor agonists suppress appetite and food reward to elicit rapid weight loss.
Practitioners can consider GLP-1 receptor agonists as effective options for weight loss.
StrongSupportsmedium confidence
GLP-1 receptor agonists for the gut peptide glucagon-like peptide 1 (GLP-1) featured prominently in anti-obesity medications by suppressing appetite and food reward to elicit rapid weight loss.
Why this rating
The claim is based on established knowledge in the context of anti-obesity medications.
Source
Neurocircuitry underlying the actions of glucagon-like peptide 1 and peptide YY3–36 in the suppression of food, drug-seeking, and anxiogenesis
Yasmina Dumiaty et al. · Neuropeptides · 2024
reviewCited 7×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →